Records containing: Sickle Cell Disease (SCD)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-20Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-16Cost of Emergency Department Boarding for Hospitalized Patients in a Statewide Medical System
-
CLINICAL_TRIALS study record update · 2026-04-15A Single Arm/ Open Label Feasibility Trial of Omega-3- Fatty Acids in Children With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-13Sickle Cell Kidney (SCeK) Biorepository
-
CLINICAL_TRIALS study record update · 2026-03-23Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-27Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2025-07-20A Phase 2,Multicenter,Open-Label Study to Assess Appropriate Dosing and to Evaluate Safety of Crizanlizumab,With or Without Hydroxyurea/Hydroxycarbamide,in Sequential,Descending Age Groups of Pediatric Sickle Cell Disease Patients With Vaso-Occlusive Crisis
-
CLINICAL_TRIALS study record update · 2025-07-08Exploratory Study on Global Reflexology Proposed in the Management of Pain in Children With Sickle Cell Disease in Vaso-occlusive Crisis
-
CLINICAL_TRIALS study record update · 2025-06-19Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease.
-
CLINICAL_TRIALS study record update · 2025-05-25Characterization of Megakaryocytic Subpopulations and the "Immune" Phenotype of Platelets of the Sickle Cell Disease Patient
-
CLINICAL_TRIALS study record update · 2025-03-20Phenotypic and Transcriptomic Description of Megakaryocytes in Sickle Cell Patient
-
CLINICAL_TRIALS study record update · 2025-01-15Relationship Between Biological Phenotype, Clinical Severity of Sickle Cell Disease, and Blood Coagulation
-
CLINICAL_TRIALS study record update · 2025-01-13A Phase 2a, Randomized, Open-Label Study to Evaluate Multiple Dosing Regimens of Subcutaneous ALXN1820 in Adult Participants With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2025-01-08An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Vaso-occlusive Crises.
-
CLINICAL_TRIALS study record update · 2025-01-07Optimizing Hydroxyurea Dosage With Pharmakokinetic in Patients Suffering of Moderate to Severe Sickle Cell Anemia
-
CLINICAL_TRIALS study record update · 2024-06-04A Phase II, Multicenter, Randomized, Open Label Two Arm Study Evaluating the Effect of Crizanlizumab + Standard of Care and Standard of Care Alone on Renal Function in Sickle Cell Disease Patients ≥ 16 Years With Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)
-
CLINICAL_TRIALS study record update · 2024-04-23A Phase 2, Multicenter, Open-Label Study to Assess PK/PD of SEG101 (Crizanlizumab), With or Without Hydroxyurea/Hydroxycarbamide, in Sickle Cell Patients With Vaso-Occlusive Crisis
-
CLINICAL_TRIALS study record update · 2024-01-08A Phase III, Multicenter, Randomized, Double-blind Study to Assess Efficacy and Safety of Two Doses of Crizanlizumab Versus Placebo, With or Without Hydroxyurea/ Hydroxycarbamide Therapy, in Adolescent and Adult Sickle Cell Disease Patients With Vaso-Occlusive Crises (STAND)
-
CLINICAL_TRIALS study record update · 2024-01-08A Phase III, Multicenter, Randomized, Double-blind Study to Assess Efficacy and Safety of Two Doses of Crizanlizumab Versus Placebo, With or Without Hydroxyurea/ Hydroxycarbamide Therapy, in Adolescent and Adult Sickle Cell Disease Patients With Vaso-Occlusive Crises (STAND)
-
CLINICAL_TRIALS study record update · 2023-07-17Studies to Facilitate the Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Biomarkers and Chest Imaging